Fuld & Company Blog

JANUARY 12, 2023

For the latest and most important 5G news and developments from November and December 2022 please see below for all the key stories. For a PDF version of this news please download here.

Communication 52

Communication 52

pharmaphorum

NOVEMBER 23, 2020

AZ made the announcemen t as the UK regulator reportedly gears up to make a decision on the rival vaccine from Pfizer and BioNTech, ahead of counterparts in the US and Europe. AZ said the trial has therefore met its main efficacy goal and will immediately prepare filings to regulators around the world to allow early approval.

Vaccines 105

Vaccines 105

pharmaphorum

AUGUST 16, 2021

The two companies have submitted data from a phase 1 trial in support of the booster dose to the US regulator, and will follow that with filings in Europe and elsewhere in the world in the coming weeks. CureVac, GSK say new-generation jab is much improved.

Vaccines 105

Vaccines Immunity Immunization 105

Pharmaceutical Technology

MAY 16, 2023

The news comes after a tricky opening quarter for Emergent. In February 2022, the FDA accepted Valneva’s vaccine candidate application for priority review after the French biotech company completed a successful Phase III trial in 2022.

Vaccines 52

Vaccines 52

European Pharmaceutical Review

OCTOBER 24, 2022

The World Health Organization (WHO) COVID-19 Vaccines Global Access (COVAX) reserved one billion doses for distribution to low-income countries. NEWS: GSK to supply Europe with 85mn pandemic flu vaccines… The post Vaccine producers promise equal access in future pandemics appeared first on European Pharmaceutical Review.

Vaccines 63

Vaccines Pharmaceutical Manufacturing 63

pharmaphorum

DECEMBER 17, 2020

It is the first publicly announced inactivated COVID-19 vaccine candidate to begin clinical development in Europe. But according to Sky News GP practices have been forced to collect data on the rollout of the vaccine shot by hand. This follows problems with the software being used to keep track of who has been given the jab.

Vaccines 105

Vaccines Immunity Immunization Hospitals 105

Fuld & Company Blog

OCTOBER 3, 2023

Although the news has not yet been confirmed, it would not be a surprise if Shell is putting the company up for sale given the recent shift in the company’s portfolio strategy. It looks like Shell is considering 1 selling battery management and utility company sonnen, which it acquired in 2019.

59

59

pharmaphorum

JUNE 18, 2021

Good results for Europe! The court judgment ordering AstraZeneca to deliver to us rapidly 50 million doses is good news for our vaccination campaign. It is also a clear recognition that our Advance Purchase Agreements have a sound legal basis. Our vaccines strategy delivers.

Vaccines 59

Vaccines 59

pharmaphorum

DECEMBER 2, 2020

Pfizer and BioNTech are preparing to deliver their COVID-19 vaccine to the UK after the country’s drugs regulator became the first authority in the world to approve it. This welcome news, however, does not mean that we are immediately out of the woods. The NHS stands ready to start vaccinating early next week.

Vaccines 88

Vaccines 88

pharmaphorum

NOVEMBER 12, 2020

In the hours after Pfizer’s momentous vaccine news emerged on Monday #pfizerproud popped up on my social media feeds again and again from the firm’s employees, both past and present. We are a significant step closer to providing people around the world with a much-needed breakthrough to help bring an end to this global health crisis.”.

Vaccines 87

Vaccines 87

Fuld & Company Blog

JANUARY 12, 2023

Every month we publish the latest news and developments relating to Corporate Venture Capital (CVC). If you would like a PDF version of this news please download here. A breakdown of the number of deals by region shows that the highest number took place in Asia (138) followed by North America (119) and Europe (64).

52

52

European Pharmaceutical Review

JUNE 27, 2023

For World Microbiome Day on 27 June 2023, EPR put questions to Hervé Affagard, CEO and co-founder of MaaT Pharma and Jeffrey Silber, Chief Medical Officer of Vedanta Biosciences, to find out how the field is progressing and what innovations could transform future microbiome-based therapies.

Immunity 98

Immunity Immunization Chemotherapy Vaccines 98

pharmaphorum

OCTOBER 13, 2021

The news sent Swedish firm CombiGene’s shares soaring – almost doubling from SEK6.29 Spark Therapeutics has secured the exclusive rights to CombiGene’s CG01 therapy, which aims to treat drug resistant focal epilepsy, in a deal worth $8.5m in advance with further payments due on reaching clinical milestones. to SEK14.10

59

59

pharmaphorum

JANUARY 31, 2022

It is becoming increasingly important for people all over the world to understand the importance of vaccines and to have access to the vaccines they need – especially with digital innovation driving new vaccine development. Innovative new vaccines are being created more rapidly than ever before. About Pfizer.

Vaccines 97

Vaccines Pharmaceutical Companies Pharmaceutical Companies Drug Development 97

pharmaphorum

FEBRUARY 24, 2021

The company released a statement saying it will meet the EU’s targets by using its global supply chain to make up for any shortfall in Europe, where it is struggling to get production up to speed. The company has not said whether its commitments to the EU will affect supply to other countries around the world.

Vaccines 64

Vaccines Documentation 64

pharmaphorum

JUNE 24, 2022

Although the World Health Organization is still rating the current monkeypox outbreak as a moderate threat , the disease has continued to spread , with 2,103 cases in 42 countries and one confirmed death, according to the latest WHO data. Accordingly, countries around the world are gearing up to address the outbreak.

Vaccines 52

Vaccines Labelling Immunity Immunization 52

pharmaphorum

JUNE 2, 2021

Capacity to supply Moderna’s COVID-19 vaccine in Europe could be swelled by round 300 million doses a year, following an agreement to set up a new production line at contract manufacturer Lonza. Full approval means it could be used routinely in future as an annual booster, much like the seasonal influenza vaccine.

Vaccines 52

Vaccines Immunity Immunization 52

pharmaphorum

APRIL 29, 2021

Founder and CEO Konstantin Mehl spoke to pharmaphorum’s news editor Richard Staines about why these treatments will be in demand as the world emerges from the pandemic. These account for around 40% of work-related injuries across the company and incidence is high with other employers across the world. About the author.

Insurance Coverage and Processing 85

Insurance Coverage and Processing 85

pharmaphorum

DECEMBER 2, 2020

Here we take a look at the colourful history of one of the biggest drugmakers in the world. In 1919 their scientists pioneered mould fermentation production of citric acid from molasses, freeing their citric acid business from European citrus fruit supplies, which had been disrupted by the First World War.

Compounding 128

Compounding Vaccines Biosimilars Diabetes 128

pharmaphorum

APRIL 7, 2021

He spoke to pharmaphorum’s news editor Richard Staines to outline his plans to create a European biotech powerhouse. . As the world ponders what is on the other side of the pandemic, van de Winkel is pleased to report that things are much better at Genmab than they were at the end of the last crisis. billion). “It About the author .

Chemotherapy 91

Chemotherapy Hospitals Vaccines 91

Quality Matters

NOVEMBER 27, 2023

A: This summer, a wave of regulatory activity on nitrosamines took place around the world, with numerous agencies publishing new or revised guidances. Official updates came out of Europe, Canada, and Japan. This is welcome news, as it’s the most restrictive category in the CPCA.

Compounding 52

Compounding 52

pharmaphorum

SEPTEMBER 18, 2020

“Picking the next merger candidate is hard enough, doing so before everyone else jumps on board, then picking the right time to sell makes for a dangerous investment game,” said one BBC News article from December 1998. The deal was instantly controversial in both Europe and the US. Blockbusters go off patent. Pascal Soriot.

Vaccines 116

Vaccines Pharmaceutical Companies Pharmaceutical Companies Drug Development 116

Pharmaceutical Technology

JULY 22, 2022

The World Health Organization (WHO) further stated that at least 18 of the children underwent liver transplants, and one had died. Helen Branswell, an infectious diseases and health reporter at the news website Stat News, shared an article on a monkeypox case being reported in the US, amid rising cases in Spain, Portugal, and Europe.

Vaccines 52

Vaccines Immunity Immunization Labelling 52

Eye on FDA

NOVEMBER 17, 2020

Coincident to COVID-19 case levels in Europe and the United States entering new and serious levels comes welcome news on the development of a vaccine. It was a much-craved dose of good news, spawning broad optimism during what is an extremely challenging phase of the pandemic.

Communication 81

Communication Vaccines HIPAA Documentation 81

pharmaphorum

FEBRUARY 19, 2021

pharmaphorum’s news editor, Richard Staines, discusses the success stories and failures in R&D that have emerged during the Q4 results period. . Many trials were put on hold during the pandemic, but pharma is under pressure to continue with work on new drugs for other diseases. Parkinson’s woes.

Vaccines 45

Vaccines Drug Development 45

STAT

MARCH 5, 2024

We hope all goes well and you conquer the world. … The White House ballyhooed a routine step in Medicare’s new program to negotiate the prices of prescription drugs, its latest effort to draw attention to the program in an election year , STAT writes. and Europe. Continue to STAT+ to read the full story…

Diabetes 203

Diabetes Pharmaceutical Companies Pharmaceutical Companies 203

pharmaphorum

JANUARY 27, 2021

is a phrase I’ve seen repeatedly on social media over the past few weeks, especially when the news broke of the Medicines and Health Products Regulatory Agency’s speedy approval of the Pfizer-BioNTech COVID-19 vaccine in the UK. Suddenly people were comparing the length of approval processes in the UK, Europe, and the US.

Vaccines 52

Vaccines Drug Development 52

The Guardian - Pharmaceutical Industry

NOVEMBER 26, 2023

Patients’ group says reactions to metamizole can cause sepsis and organ failure – and British and Irish people are at higher risk A patients group representing several British victims has launched legal action against the Spanish government over claims it failed to safeguard people against the potentially fatal side effects of one of the country’s (..)

98

98

Pharma Marketing Network

JUNE 11, 2020

The biggest difference I think is while you were a kind of a sole voice, and you know, starting with news and conference coverage, and then evolving into more opinion pieces about the industry in a bit of a watchdog. So, you continue with Pharma Marketing news. So, from a news perspective, if they can cover that’s wonderful.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing Labelling 52

pharmaphorum

APRIL 16, 2021

Taking the longer term view of the last seven years, 2020 was a rather good year for innovative medicine approvals in both the US and Europe – an improvement on 2019, even with the extra approvals of COVID treatments and the first of the vaccines accounted for. The post Three pillars of post-pandemic launch excellence appeared first on.

Pharmaceutical Companies 95

Pharmaceutical Companies Pharmaceutical Companies Vaccines Documentation 95

The Guardian - Pharmaceutical Industry

OCTOBER 24, 2023

Health regulator says serious side-effects possibly caused by insulin in counterfeit versions of Novo Nordisk’s Ozempic Several people have been admitted to hospital in Austria after using suspected fake versions of Novo Nordisk’s diabetes drug Ozempic, the country’s health safety body has said, the first report of harm to users as a European hunt (..)

Diabetes 49

Diabetes Hospitals 49

The Guardian - Pharmaceutical Industry

NOVEMBER 2, 2023

Novo Nordisk says it struggling to keep up with demand after becoming Europe’s most valuable company Business live – latest updates The maker of blockbuster weight-loss drug semaglutide has reported a steep rise in sales and profits as health systems around the world rush to use it to tackle obesity.

Diabetes 46

Diabetes Pharmaceutical Companies Pharmaceutical Companies 46

The Guardian - Pharmaceutical Industry

APRIL 27, 2023

Pascal Soriot says decline in startups across Europe differs markedly from ‘explosion’ of firms and clinical trials in China The boss of Britain’s biggest drugmaker has said that the UK and the rest of Europe are falling behind China and the US in the creation of biotech firms and clinical trials of new medicines.

45

45

The Guardian - Pharmaceutical Industry

JULY 14, 2022

European Commission ‘gave no good reason’ why its president’s messages with Pfizer were not released The EU’s official watchdog has issued a formal reprimand to the European Commission over its president Ursula von der Leyen’s failure to release text messages exchanged with the boss of Pfizer during the pandemic.

52

52

pharmaphorum

JANUARY 26, 2023

In 2018, England was the first country in Europe to provide access to a CAR-T cell therapy to treat these blood cancers, enabled via the Cancer Drugs Fund (CDF). Today’s news is encouraging, as it shows that even in the real-world setting these therapies are living up to their expectations for patients with aggressive forms of lymphoma.”

Chemotherapy 96

Chemotherapy Immunity Immunization Hospitals 96

pharmaphorum

MARCH 25, 2022

The new plant adds to Jazz’s existing presence at KSP, where it employs around 400 staff across 12 buildings. ” The new plant is being deigned with consideration of the environment, and will feature animal refuge boxes to promote wildlife, more than 1,100 solar panels to provide energy and minimised use of single-use plastics.

Chemotherapy 98

Chemotherapy Pharmaceutical Manufacturing 98

The Nontraditional Pharmacist

NOVEMBER 20, 2019

So we have offices in the US, in Europe, Asia, Mumbai, India, as well as in South America. And even in now, just recently in Abu Dhabi and the United Arab Emirates and our learners are all over the world. You know, we get people from all over the world. Will [00:02:40] Absolutely. So, the ACMA is a global organization.

Communication 52

Communication Drug Pricing 52